Description

The integration of precision medicine-related findings into the clinic is essential if field is to succeed. I developed clinical practice guidelines to aid in pharmacogenomic decision making in cancer to help achieve this goal. I have also been involved in the development of a pharmacogenomics testing panel that will be available throughout Canada with the support of a $3 million grant.

Further, I am currently engaged in activities related to molecular therapeutics in Huntington disease, by refining antisense molecules to silence mutant protein by incorporating the use of population genetics data.